Search

Your search keyword '"MS Interne Geneeskunde"' showing total 587 results

Search Constraints

Start Over You searched for: Author "MS Interne Geneeskunde" Remove constraint Author: "MS Interne Geneeskunde"
587 results on '"MS Interne Geneeskunde"'

Search Results

1. Bruch's Membrane Calcification in Pseudoxanthoma Elasticum: Comparing Histopathology and Clinical Imaging

4. Balancing risks of recurrent venous thromboembolism and bleeding with extended anticoagulation: a decision analysis

5. Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen

6. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model

7. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort

8. Association of body mass index and waist circumference with long-term mortality risk in 10,370 coronary patients and potential modification by lifestyle and health determinants

9. Prevalence and determinants of self-reported low-fat-, low-salt-, and vegetarian diets in patients with cardiovascular disease between 1996 and 2019

10. Thinner inner retinal layers are associated with lower cognitive performance, lower brain volume, and altered white matter network structure-The Maastricht Study

11. Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis

12. Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts

13. Impact of the 2021 European Society for Cardiology prevention guideline’s stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease

14. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC

15. Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial

17. Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease

18. The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial

20. Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials

21. Differences in checkpoint-inhibitor-induced hypophysitis: mono- versus combination therapy induced hypophysitis

22. External validation of the SI2NCAL2C score for outcomes following cerebral venous thrombosis

23. Dietary habits and compliance with dietary guidelines in patients with established cardiovascular disease

25. HbA1cand fasting plasma glucose levels are equally related to incident cardiovascular risk in a high CVD risk population without known diabetes

27. Origins and Previous Applications of Causal-Benefit Models

28. Association of physical activity and sports participation with insulin resistance and non-alcoholic fatty liver disease in people with type 1 diabetes

29. Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis

30. Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension

31. Potency of quality indicators in Dutch and international diabetes registries

32. Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and Finland

33. Call for effective therapies for preventing dementia in people with type 2 diabetes

34. Mortality patterns in Dutch diabetes outpatients

35. The Natural Course of Arterial Calcifications in Pseudoxanthoma Elasticum: A Prospective Cohort Study

36. Cyclical Etidronate Reduces the Progression of Arterial Calcifications in Patients with Pseudoxanthoma Elasticum: A 6-Year Prospective Observational Study

37. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

38. Predictors of bleeding complications during catHeter-dirEcted thrombolysis for peripheral arterial occlusions (POCHET)

39. No Evidence for an Association of HIV and Antiviral Treatment With Changes in Framingham Cardiovascular Risk Score in the Ndlovu Cohort Study

40. Potential impact of a new sepsis prediction model for the primary care setting: early health economic evaluation using an observational cohort

41. Microvascular Dysfunction and Whole-Brain White Matter Connectivity: The Maastricht Study

43. Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controls

44. Association between lower extremity arterial calcification and coronary arterial calcification in a population at increased risk of cardiovascular disease

45. Intracranial arteriosclerosis and the risk of dementia: A population-based cohort study

46. Do pseudoxanthoma elasticum patients have higher prevalence of kidney stones on computed tomography compared to hospital controls?

47. Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study

48. Long-term lifestyle change and risk of mortality and type 2 diabetes in patients with cardiovascular disease

49. Pulmonary Computed Tomography Screening Frequency in Primary Antibody Deficiency

50. Trends in body mass index in the pre-dolutegravir period in South Africa

Catalog

Books, media, physical & digital resources